Literature DB >> 12504061

Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation.

Karen Venables1, Elizabeth A Winfield, Edwin G A Aird, Peter J Hoskin.   

Abstract

PURPOSE: To examine the ability of computer planning systems to calculate the dose to the breast correctly in three dimensions. Both the absolute dose at the center of the breast and the accuracy of the isodose distributions were investigated. METHODS AND MATERIALS: Measurements were performed in a water-filled breast phantom using an ionization chamber. Thirty-six sets of data obtained during the Standardization of Breast Radiotherapy breast fractionation trial quality assurance program were included in the analysis. The planning systems were grouped according to the algorithms used on the basis of the definitions given in International Commission on Radiation Units and Measurements Report No. 24.
RESULTS: Thirty-two of the 36 planning systems overestimated the dose to the center of the breast, with a mean measured/calculated dose ratio of 0.979 (SD 0.013). The relative dose within 2 cm of the lung was also overestimated.
CONCLUSION: Only one algorithm (collapsed cone) investigated in this study was able to calculate the dose at the center of the breast correctly in tangential breast radiotherapy. With modern algorithms, it is important to include a correction for the lower density of the lung, because the dose close to the interface between breast and lung tissue will also be lower than anticipated.

Entities:  

Mesh:

Year:  2003        PMID: 12504061     DOI: 10.1016/s0360-3016(02)03808-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Authors:  Catharine H Clark; Edwin G A Aird; Steve Bolton; Elizabeth A Miles; Andrew Nisbet; Julia A D Snaith; Russell A S Thomas; Karen Venables; David I Thwaites
Journal:  Br J Radiol       Date:  2015-09-02       Impact factor: 3.039

2.  Inter-departmental dosimetry audits - development of methods and lessons learned.

Authors:  David J Eaton; Steve Bolton; Russell A S Thomas; Catharine H Clark
Journal:  J Med Phys       Date:  2015 Oct-Dec

3.  Assessment of the accuracy of dose calculation in the build-up region of the tangential field of the breast for a radiotherapy treatment planning system.

Authors:  Bagher Farhood; Mohammad Taghi Bahreyni Toossi; Shokouhozaman Soleymanifard; Tohid Mortezazadeh
Journal:  Contemp Oncol (Pozn)       Date:  2017-09-29

Review 4.  Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Authors:  Mareike K Thompson; Philip Poortmans; Anthony J Chalmers; Corinne Faivre-Finn; Emma Hall; Robert A Huddart; Yolande Lievens; David Sebag-Montefiore; Charlotte E Coles
Journal:  Br J Cancer       Date:  2018-07-31       Impact factor: 7.640

5.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet       Date:  2008-03-19       Impact factor: 79.321

6.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet Oncol       Date:  2008-03-19       Impact factor: 41.316

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.